Skip to main content

Table 2 Plasma fatty acid profile (mol%) at birth in term and preterm infants

From: Plasma arachidonic and docosahexaenoic acids in Tunisian very low birth weight infants: status and association with selected neonatal morbidities

  Term infants Preterm infants
  (n = 339) All (n = 709) Without GD or PE in mothers (n = 482)
Palmitic acid (C16:0) 30.0 (2.56) 30.5 (2.25)** 30.6 (2.29)**
Stearic acid (C18:0) 10.0 (1.62) 10.7 (1.54)*** 10.7 (1.53)***
Oleic acid (C18:1 n-9) 24.8 (2.57) 27.2 (2.11)*** 27.3 (2.01)***
Linoleic acid (C18:2 n-6) 10.7 (1.99) 9.37 (2.14)*** 9.27 (2.14)***
Alpha Linolenic acid (C18:3 n-3) 0.39 (0.17) 0.31 (0.12)*** 0.30 (0.12)***
Arachidonic acid (C20:4 n-6) 10.8 (2.10) 9.44 (2.12)*** 9.35 (2.09)***
Eicosapentaenoic acid (C20:5 n-3) 0.54 (0.32) 0.52 (0.30)** 0.48 (0.30)**
Docosahexaenoic acid (C22:6 n-3) 3.46 (1.09) 2.56 (0.89)*** 2.55 (0.88)***
Saturated fatty acids (SFAs) 41.2 (3.29) 42.7 (3.20)*** 42.8 (3.25)***
Monounsaturated fatty acids (MUFAs) 29.9 (2.90) 32.7 (2.56)*** 32.8 (2.47)***
Polyunsaturated fatty acids (PUFAs) 28.8 (4.39) 24.7 (5.01)*** 24.5 (4.96)***
Essential fatty acids (EFAs) 11.1 (2.03) 9.71 (2.24)*** 9.61 (2.24)***
n-6:n-3 PUFAs 5.17 (1.46) 5.58 (1.22)*** 5.51 (1.16)***
  1. GD gestational diabetes, PE preeclampsia; SFAs = C14:0 + C16:0 + C18:0; MUFAs = C16:1 n-7 + C18:1 n-9; EFAs = C18:2 n-6 + C18:3 n-3; PUFAs = n-6 PUFAs (C18:2 n-6 + C18:3 n-6 + C20:3 n-6 + C20:4 n-6) + n-3 PUFAs (C18:3 n-3 + C22:5 n-3 + C22:6 n-3)
  2. Values represent mean (SD); **, p < 0.01, ***, p < 0.001 (compared to term infants)